David D McManus1, Lea M Beaulieu, Eric Mick, Kahraman Tanriverdi, Martin G Larson, John F Keaney, Emelia J Benjamin, Jane E Freedman. 1. From the National Heart Lung and Blood Institute's and Boston University's Framingham Heart Study, Framingham, MA (D.D.M., K.T., M.G.L., J.E.F.); Cardiology Division, Department of Medicine (D.D.M, L.M.B., K.T., J.F.K., J.E.F.) and Epidemiology Division, Department of Quantitative Health Sciences (D.D.M, E.M.), University of Massachusetts Medical School, Worcester, MA; Section of Cardiovascular Medicine, Department of Medicine (E.J.B.) and Department of Mathematics and Statistics (M.G.L.), Boston University, Boston, MA; Preventive Medicine Section, Department of Medicine, Boston University School of Medicine, Boston, MA (E.J.B.); and Department of Epidemiology (E.J.B.) and Department of Biostatistics (M.G.L.), Boston University School of Public Health, Boston, MA.
Abstract
OBJECTIVE: Cardiovascular disease is a complex disorder influenced by interactions of genetic variants with environmental factors. However, there is no information from large community-based studies examining the relationship of circulating cell-specific RNA to inflammatory proteins. In light of the associations among inflammatory biomarkers, obesity, platelet function, and cardiovascular disease, we sought to examine the relationships of C-reactive protein (CRP) and interleukin-6 (IL-6) to the expression of key inflammatory transcripts in platelets. APPROACH AND RESULTS: We quantified circulating levels of CRP and IL-6 in 1625 participants of the Framingham Heart Study (FHS) Offspring cohort examination 8 (mean age, 66.6 ± 6.6 years; 46% men). We measured the expression of 15 relevant genes by high-throughput quantitative reverse transcriptase polymerase chain reaction from platelet-derived RNA and used multivariable regression to relate serum concentrations of CRP and IL-6 with gene expression. Levels of CRP and IL-6 were associated with 10 of the 15 platelet-derived inflammatory transcripts, ALOX5, CRP, IFIT1, IL6, PTGER2, S100A9, SELENBP1, TLR2, TLR4, and TNFRSF1B (P<0.001). Associations between platelet mRNA expression with CRP and IL-6 persisted after multivariable adjustment for potentially confounding factors. Six genes positively associated with CRP or IL-6 in the FHS sample were also upregulated in megakaryocytes in response to CRP or IL-6 exposure. CONCLUSIONS: Our data highlight the strong connection between the circulating inflammatory biomarkers CRP and IL-6 and platelet gene expression, adjusting for cardiovascular disease risk factors. Our results also suggest that body weight may directly influence these associations.
OBJECTIVE:Cardiovascular disease is a complex disorder influenced by interactions of genetic variants with environmental factors. However, there is no information from large community-based studies examining the relationship of circulating cell-specific RNA to inflammatory proteins. In light of the associations among inflammatory biomarkers, obesity, platelet function, and cardiovascular disease, we sought to examine the relationships of C-reactive protein (CRP) and interleukin-6 (IL-6) to the expression of key inflammatory transcripts in platelets. APPROACH AND RESULTS: We quantified circulating levels of CRP and IL-6 in 1625 participants of the Framingham Heart Study (FHS) Offspring cohort examination 8 (mean age, 66.6 ± 6.6 years; 46% men). We measured the expression of 15 relevant genes by high-throughput quantitative reverse transcriptase polymerase chain reaction from platelet-derived RNA and used multivariable regression to relate serum concentrations of CRP and IL-6 with gene expression. Levels of CRP and IL-6 were associated with 10 of the 15 platelet-derived inflammatory transcripts, ALOX5, CRP, IFIT1, IL6, PTGER2, S100A9, SELENBP1, TLR2, TLR4, and TNFRSF1B (P<0.001). Associations between platelet mRNA expression with CRP and IL-6 persisted after multivariable adjustment for potentially confounding factors. Six genes positively associated with CRP or IL-6 in the FHS sample were also upregulated in megakaryocytes in response to CRP or IL-6 exposure. CONCLUSIONS: Our data highlight the strong connection between the circulating inflammatory biomarkers CRP and IL-6 and platelet gene expression, adjusting for cardiovascular disease risk factors. Our results also suggest that body weight may directly influence these associations.
Authors: Hakon Hakonarson; Struan F A Grant; Jonathan P Bradfield; Luc Marchand; Cecilia E Kim; Joseph T Glessner; Rosemarie Grabs; Tracy Casalunovo; Shayne P Taback; Edward C Frackelton; Margaret L Lawson; Luke J Robinson; Robert Skraban; Yang Lu; Rosetta M Chiavacci; Charles A Stanley; Susan E Kirsch; Eric F Rappaport; Jordan S Orange; Dimitri S Monos; Marcella Devoto; Hui-Qi Qu; Constantin Polychronakos Journal: Nature Date: 2007-07-15 Impact factor: 49.962
Authors: Harald H H Göring; Joanne E Curran; Matthew P Johnson; Thomas D Dyer; Jac Charlesworth; Shelley A Cole; Jeremy B M Jowett; Lawrence J Abraham; David L Rainwater; Anthony G Comuzzie; Michael C Mahaney; Laura Almasy; Jean W MacCluer; Ahmed H Kissebah; Gregory R Collier; Eric K Moses; John Blangero Journal: Nat Genet Date: 2007-09-16 Impact factor: 38.330
Authors: Renate Schnabel; Martin G Larson; Josée Dupuis; Kathryn L Lunetta; Izabella Lipinska; James B Meigs; Xiaoyan Yin; Jian Rong; Joseph A Vita; Christopher Newton-Cheh; Daniel Levy; John F Keaney; Ramachandran S Vasan; Gary F Mitchell; Emelia J Benjamin Journal: Hypertension Date: 2008-04-21 Impact factor: 10.190
Authors: Ravi Dhingra; Philimon Gona; Byung-Ho Nam; Ralph B D'Agostino; Peter W F Wilson; Emelia J Benjamin; Christopher J O'Donnell Journal: Am J Med Date: 2007-12 Impact factor: 4.965
Authors: Sekar Kathiresan; Olle Melander; Candace Guiducci; Aarti Surti; Noël P Burtt; Mark J Rieder; Gregory M Cooper; Charlotta Roos; Benjamin F Voight; Aki S Havulinna; Björn Wahlstrand; Thomas Hedner; Dolores Corella; E Shyong Tai; Jose M Ordovas; Göran Berglund; Erkki Vartiainen; Pekka Jousilahti; Bo Hedblad; Marja-Riitta Taskinen; Christopher Newton-Cheh; Veikko Salomaa; Leena Peltonen; Leif Groop; David M Altshuler; Marju Orho-Melander Journal: Nat Genet Date: 2008-01-13 Impact factor: 38.330
Authors: Pavel N Shashkin; G Thomas Brown; Arundhati Ghosh; Gopal K Marathe; Thomas M McIntyre Journal: J Immunol Date: 2008-09-01 Impact factor: 5.422
Authors: V D F de Mello; M Kolehmainen; L Pulkkinen; U Schwab; U Mager; D E Laaksonen; L Niskanen; H Gylling; M Atalay; R Rauramaa; M Uusitupa Journal: Diabetologia Date: 2008-08-30 Impact factor: 10.122
Authors: Paula V Nersesian; Hae-Ra Han; Gayane Yenokyan; Roger S Blumenthal; Marie T Nolan; Melissa D Hladek; Sarah L Szanton Journal: Soc Sci Med Date: 2018-04-30 Impact factor: 4.634
Authors: Lea M Beaulieu; Elaine Lin; Eric Mick; Milka Koupenova; Ellen O Weinberg; Carolyn D Kramer; Caroline A Genco; Kahraman Tanriverdi; Martin G Larson; Emelia J Benjamin; Jane E Freedman Journal: Arterioscler Thromb Vasc Biol Date: 2014-01-23 Impact factor: 8.311
Authors: David D McManus; Honghuang Lin; Kahraman Tanriverdi; Michael Quercio; Xiaoyan Yin; Martin G Larson; Patrick T Ellinor; Daniel Levy; Jane E Freedman; Emelia J Benjamin Journal: Heart Rhythm Date: 2014-01-18 Impact factor: 6.343
Authors: Christine M Willinger; Jian Rong; Kahraman Tanriverdi; Paul L Courchesne; Tianxiao Huan; Gregory A Wasserman; Honghuang Lin; Josée Dupuis; Roby Joehanes; Matthew R Jones; George Chen; Emelia J Benjamin; George T O'Connor; Joseph P Mizgerd; Jane E Freedman; Martin G Larson; Daniel Levy Journal: Circ Cardiovasc Genet Date: 2017-10